Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Chemoprevention × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

HhAntag691 21 Imiquimod 12 Biopsy 9 Aminolevulinic Acid 9 Photochemotherapy 8 sonidegib 7 1-phenyl-3,3-dimethyltriazene 7 methyl 5-aminolevulinate 6 cemiplimab 5 Tomography, Optical Coherence 5 Surgical Procedures, Operative 5 Nivolumab 5 pembrolizumab 4 Radiotherapy 4 Mohs Surgery 4 Itraconazole 4 Curettage 4 Standard of Care 3 Specimen Handling 3 Niacinamide 3 Microscopy, Confocal 3 IPI-926 3 tazarotene 2 talimogene laherparepvec 2 daromun 2 Watchful Waiting 2 Sirolimus 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Laser Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡